IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorSamsung Medical Center
About this trial
The aim of the study is to compare clinical outcomes between intravascular ultrasound (IVUS)-guided treatment decision versus fractional flow reserve (FFR)-guided treatment decision for non-infarct related artery stenosis in patients with acute myocardial infarction (AMI) and multivessel disease.
Eligibility criteria
Qualifiers
Subject must be at least 19 years of age
Acute ST-segment elevation myocardial infarction (STEMI)
Acute non-ST-segment elevation myocardial infarction (NSTEMI)
Symptoms of ischemia.
Disqualifiers
Non-IRA stenosis not amenable for PCI treatment by operators' decision
Cardiogenic shock (Killip class IV) already at presentation or the completion of IRA PCI
Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparin, or Everolimus
Known true anaphylaxis to contrast medium (not allergic reaction but anaphylactic shock)
Trial design
Treatments tested in this trial
- IVUS-guided PCI group
- FFR-guided PCI group
Treatment groups
1,400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Samsung Medical Center
Lead sponsor
Chonnam National University
Collaborator
Source ClinicalTrials.gov